MERITAGE PORTFOLIO MANAGEMENT - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 215 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
MERITAGE PORTFOLIO MANAGEMENT ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$690
+23.2%
25,319
+0.6%
0.05%
+27.5%
Q2 2023$560
+32.1%
25,173
+28.5%
0.04%
+25.0%
Q1 2023$424
+6.3%
19,588
-0.4%
0.03%
+3.2%
Q4 2022$399
-99.9%
19,662
+3.2%
0.03%
-24.4%
Q3 2022$489,000
+11.6%
19,055
+3.4%
0.04%
+20.6%
Q2 2022$438,000
+3.1%
18,422
-2.4%
0.03%
+30.8%
Q1 2022$425,000
+104.3%
18,878
+79.8%
0.03%
+116.7%
Q4 2021$208,00010,5000.01%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,712,176$123,147,0006.01%
TANAKA CAPITAL MANAGEMENT INC 74,139$1,048,0003.38%
S&T BANK/PA 625,078$8,859,0001.92%
Parallel Advisors, LLC 1,277,851$18,062,0001.55%
AJ WEALTH STRATEGIES, LLC 595,828$8,422,0001.11%
Matarin Capital Management, LLC 891,636$12,603,0000.95%
Capital Impact Advisors, LLC 162,544$2,370,0000.90%
AMI ASSET MANAGEMENT CORP 775,685$10,964,0000.57%
Birchview Capital, LP 50,000$707,0000.47%
Zebra Capital Management LLC 25,409$359,0000.39%
View complete list of CORCEPT THERAPEUTICS INC shareholders